At the Sustainable Manufacturing conference track of the 6th Annual BioPharma Asia Convention 2013, Dr Arvind Mishra, Joint President of Corporate QC/QA&RA, Cadila Pharmaceuticals India presented on the topic “Leveraging on the latest technology to boost productivity in drug manufacturing”
Dr Mishra has more than 25 years of rich experience in the field of Quality Control, Global Quality Assurance, GMP compliance and National and Interationational Regulatory Affairs. He has been closely interacting with Indian and various International Regulatory authorities around the world and helped companies increase presence and export business internationally by registering more than 1500 product dossiers including INDs ANDAs and several DMFs and COSs.
The key agenda of the presentation is:
– Benchmarking the latest processes in drug production
– Assessing the latest technologies to increase drug throughput in India
– Evaluating the long term benefits of implementing novel technologies versus their implementation costs
For more information about BioPharma Asia Convention 2014, visit our website here >